Genedata Biopharma Platform: Biopharma Automation & AI
Genedata Biopharma Platform Digitalizing Biopharma
Purpose-Built. Proven.
All top 25 biopharmaceutical companies and cutting-edge biotechs everywhere use the Genedata Biopharma Platform to reduce costs, accelerate workflows, and improve overall productivity.
The Genedata Biopharma Platform enables automation of complex R&D processes for any therapeutic format and modality.
Unique. Game-Changing.
The Genedata Biopharma Platform offers built-in business logic and open architecture. It integrates workflows and automates operations, thereby eliminating bottlenecks, fostering collaboration, and empowering the establishment of novel R&D technologies and processes.
AI-Powered Analytics. Data-Driven Decisions.
The AI revolution is transforming R&D. With the Genedata Biopharma Platform, biopharmas can lead this change. Its AI-driven workflows automate routine phenotype classification, signal denoising, and assay curve interpretation, freeing scientific experts to focus on innovation. AI agents assist data scientists with data discovery and analysis, with human-in-the-loop validation for GxP settings.
Success in AI-powered drug discovery depends on high-quality, AI-ready data. The Genedata Biopharma Platform provides structured, annotated, traceable datasets and an integrated environment for AI model testing and deployment, enabling reliable, AI-driven predictions, decisions, and insights.
A Modular Platform.
The Genedata Biopharma Platform is an end-to-end solution that covers key workflows and technologies in biopharma. Capabilities include data analysis and management of chromatography, mass spectrometry, next-generation sequencing and other omics data, in vitro or in vivo assay data, and clinical data. The platform also streamlines molecule design, registration, testing, and process development for biotherapeutics. Leverage one or more platform components to fit your organization’s needs. Or, maximize the benefits of a single, central system by deploying the complete platform.